Developer docs
API playgroundTry for free, no card

Search company profiles

CIONIC

Full company profile

uuid00008yu

Namestring
CIONIC
Legal namestring
Cionic, Inc.
Websiteurl
cionic.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

CIONIC (Cionic, Inc.) is a privately held neurotechnology company headquartered in Scotts Valley, California, that develops the FDA-cleared Neural Sleeve, a wearable bionic garment for individuals with neurological conditions affecting mobility, including multiple sclerosis, stroke, cerebral palsy, spinal cord injury, and traumatic brain injury. The company's core technology, MultiStim, combines functional electrical stimulation with continuous afferent stimulation and proprietary adaptive algorithms driven by on-device IMU kinematics and sEMG sensors; the system can interleave up to 12 independent pulse trains to simultaneously activate weak muscles and relax spastic muscles in real time. CIONIC monetizes through a hardware-plus-recurring-subscription model: a down payment plus monthly installments during Year 1 totaling $3,600 (single leg) or $6,200 (dual leg), transitioning to a $125-$200/month subscription for ongoing Mobility Specialist support, electrodes, and warranty, with a refurbished option at $875 and a side-exchange path for upgrades.

The company operates a multi-channel go-to-market combining direct-to-consumer e-commerce with a 30-second online assessment and virtual onboarding, a prescriber channel of 1,500 physicians and physical therapists nationwide, and a federal channel via its partnership with Lovell Government Services providing veterans access through the VA. CIONIC has raised approximately $35.25 million across five funding rounds through October 2023, with L Catterton (lead, 2023) and BlueRun Ventures (lead, 2022) as flagship investors. It has established clinical and research partnerships with Shirley Ryan AbilityLab, Stanford University, and the National MS Society, and has accumulated 2 million hours of real-world wear time and 500 million stimulated steps across its user base. The Neural Sleeve 2, cleared by the FDA in September 2025, expanded indications to include simultaneous muscle activation and spasm relaxation, and was named a TIME Best Invention of 2025 and Fast Company Most Innovative Company for 2026.

Short descriptiontext

CIONIC builds the FDA-cleared Neural Sleeve, an AI-powered wearable neurotech device using multi-electrode functional electrical stimulation to improve walking for individuals with neurological conditions including MS, stroke, cerebral palsy, and spinal cord injury, sold direct-to-consumer, through 1,500 prescribers, and via the VA channel.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wearable neurotechnology, functional electrical stimulation, mobility assistance devices, neurological rehabilitation tech, bionic clothing
Industry3 codes
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHDACAFAL
Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards)
Hardware, Technology & Telecom/Computing Hardware & Peripherals/Input Devices & Accessories (Keyboards, Mice, Controllers)
SECONDARYHDACALAH
Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Wearable Neurotechnology / Medical Mobility Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Neural Sleeve Hardware Sales
TypeHardware Sales
Description

Sale of the Neural Sleeve wearable device, which includes the sleeve garment, control unit, and accessories. Customers pay a down payment followed by monthly installments over 12 months, then transition to subscription for ongoing support.

cionic.com
2Subscription Services
TypeSubscription Recurring
Description

Ongoing monthly subscription after the first 12 months at $125/month for single leg or $200/month for dual leg. Includes Mobility Specialist support, electrode supply, and extended warranty coverage. Year 1 totals $3,600 (single) or $6,200 (dual).

cionic.com
3Refurbished Device Sales
TypeOne Time License
Description

One-time purchase option for prior-generation Neural Sleeves at $875, available through the Certified Refurbished Program. Includes 3 months of service with option to enroll in ongoing subscription.

cionic.com
4Professional Services
TypeProfessional Services
Description

Mobility Specialist onboarding and follow-up sessions, Fit Confirmation appointments, and a la carte services for customers not on subscription plans.

cionic.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details6 tiers
1Single Neural Sleeve - Year 1
ModelSubscriptionBilling cadenceMonthly
Notes

$300 down payment + $275/month × 11 months = $3,600 total for first year. Includes Neural Sleeve, control unit, accessories, and onboarding.

cionic.com
2Dual Neural Sleeve - Year 1
ModelSubscriptionBilling cadenceMonthly
Notes

$500 down payment + $475/month × 11 months = $6,200 total for first year. For users requiring assistance on both legs.

cionic.com
3Single Neural Sleeve - Year 2+
ModelSubscriptionBilling cadenceMonthly
Notes

$125/month plus applicable taxes. Includes ongoing Mobility Specialist support, electrode supply, and extended warranty.

cionic.com
4Dual Neural Sleeve - Year 2+
ModelSubscriptionBilling cadenceMonthly
Notes

$200/month plus applicable taxes.

cionic.com
5Refurbished Neural Sleeve
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$875 one-time purchase (plus taxes and shipping). Includes 3 months of Mobility Specialist service, electrode supply, and app access. After 3 months, can enroll in subscription at then-current rate.

cionic.com
6Side Exchange
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$725 one-time switching fee ($450 for new sleeve + $275 for new onboarding) plus taxes and shipping to change from single to dual or vice versa.

cionic.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CIONIC designs, manufactures, and sells the FDA-cleared Neural Sleeve, a wearable neurotechnology garment that uses AI-powered MultiStim functional electrical stimulation combined with continuous afferent stimulation to improve walking in individuals with neurological conditions such as multiple sclerosis, cerebral palsy, stroke, spinal cord injury, and traumatic brain injury. The system is delivered through an online assessment and prescription workflow, with the Cionic companion app for personalized control and ongoing support from Mobility Specialists, sold via a hardware-plus-subscription model.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 94% of participants experienced improved gait
+7 more records
Product overview1 text field

CIONIC offers a unified bionic mobility system consisting of the Neural Sleeve (a wearable neurotech device combining FDA-cleared Functional Electrical Stimulation with AI-powered real-time gait analysis), the companion Cionic App (for personalized control and progress tracking), and Mobility Specialists (for onboarding and ongoing support). The company also offers a separate Cionic Research Kit for academic and clinical researchers conducting human mobility studies.

Product and service5 records
1Neural Sleeve 2
CategoryWearable neurotechnology / medical mobility device
Description

FDA-cleared bionic clothing garment that uses AI-powered MultiStim technology combining functional electrical stimulation and continuous afferent stimulation to improve walking, activate functional muscle movement, and relax muscle spasms for individuals with neurological conditions including MS, cerebral palsy, stroke, and spinal cord injury.

2Certified Refurbished Neural Sleeve
CategoryWearable neurotechnology / medical mobility device
Description

One-time-purchase refurbished Neural Sleeve at $875 that includes the device, 3 months of Mobility Specialist service, electrode supply, and app access, with the option to enroll in the ongoing subscription afterward. Intended for cost-sensitive consumers who want hardware access without committing to the full subscription.

3Cionic App
CategoryCompanion software / mobile application
Description

iOS and Android companion application for Neural Sleeve users that delivers progress measurement, personalized muscle stimulation control, and a growing library of training programs. Sold as part of the Neural Sleeve subscription bundle.

4Mobility Specialist Support Service
CategoryProfessional clinical support service
Description

Expert-led onboarding, program tailoring, and ongoing support delivered by CIONIC's Mobility Specialists to Neural Sleeve users. Included with active subscriptions and available à la carte for non-subscribers.

5Cionic Research Kit
CategoryResearch platform / data infrastructure
Description

Standalone research platform for academic and clinical investigators conducting human mobility studies, providing hardware sensors (IMU kinematics up to 400 Hz, sEMG up to 4 kHz), mobile and web applications, a Jupyter analysis environment, HIPAA-compliant infrastructure, and SDKs/REST APIs. Targets research institutions such as Shirley Ryan AbilityLab and Stanford University.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-10-01
Description

Partnership with veteran-owned business Lovell Government Services to enhance veterans' access to the Cionic Neural Sleeve through federal healthcare systems. Aims to improve mobility for veterans with neurological conditions including MS.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical and research partnership with leading rehabilitation research hospital for evidence development and validation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partnership for human motion and gait research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with leading MS advocacy organization for research and community support.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Bioness is a direct competitor in functional electrical stimulation devices for foot drop and gait rehabilitation, with FDA-cleared L300 Go and H200 products. Both companies target the same neurological mobility patient population with similar FES technology, though CIONIC differentiates with AI-driven adaptive multi-channel stimulation.

TypeBroad incumbent
Description

Ottobock is a global incumbent in prosthetics, orthotics, and rehabilitation technology with FES products (e.g., L300 Go via acquisition) and broader mobility aids. Comparable because they sell competing FES solutions and complementary mobility devices through established clinical channels and reimbursement networks.

TypeDirect peer
Description

Saebo develops rehabilitation devices for stroke, neurological injury, and mobility impairment, including functional electrical stimulation products and orthoses. Comparable because both companies target the same neurological patient population with clinical evidence-based rehabilitation technology.

TypeEmerging player
Description

Ekso Bionics builds robotic exoskeletons for rehabilitation and mobility assistance in stroke, spinal cord injury, and multiple sclerosis. Comparable because they target the same neurological mobility patient population, though using mechanical exoskeleton technology rather than FES-based wearable stimulation.

TypeEmerging player
Description

ReWalk Robotics develops wearable robotic exoskeletons for individuals with spinal cord injury and other mobility impairments. Comparable in targeting neurological mobility patients with FDA-cleared wearable technology, though using a different modality (powered exoskeleton vs. FES).

6Compex
TypeDirect peer
Description

Compex (DJO/Enovis) is a leading brand in electrical muscle stimulation devices for rehabilitation, sports performance, and pain management. Comparable because both offer neuromuscular electrical stimulation technology for muscle activation and recovery, though Compex is more consumer/clinical-rehab oriented and CIONIC is more neurological-condition focused.

TypeBroad incumbent
Description

Enovis (formerly DJO) is a large medical device company with a broad portfolio in orthopedic, rehabilitation, and pain management products including FES devices. Comparable as a broader incumbent competing in the same FES/rehabilitation space with established payer relationships and clinical sales channels.

8Hasomed
TypeDirect peer
Description

Hasomed develops the RehaMove functional electrical stimulation device for gait rehabilitation and therapy in neurological patients. Comparable as a direct FES competitor in the same patient population, though primarily a clinical/rehab setting device vs. CIONIC's consumer wearable approach.

TypeEmerging player
Description

NeuroPace develops implantable neurostimulation devices (RNS System) for epilepsy with closed-loop responsive stimulation. Comparable as a neurotechnology company applying AI-driven adaptive stimulation to neurological conditions, though in an implantable form factor for a different indication.

TypeBroad incumbent
Description

LivaNova is a global neuromodulation and cardiac surgery company with VNS (vagus nerve stimulation) therapy for epilepsy and depression. Comparable as a broader incumbent in neuromodulation technology applied to neurological conditions, though focused on implantable vagus nerve stimulation rather than wearable FES.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CIONIC

Wearable Neurotechnology / Medical Mobility Devicescionic.com

CIONIC builds the FDA-cleared Neural Sleeve, an AI-powered wearable neurotech device using multi-electrode functional electrical stimulation to improve walking for individuals with neurological conditions including MS, stroke, cerebral palsy, and spinal cord injury, sold direct-to-consumer, through 1,500 prescribers, and via the VA channel.

What CIONIC does

CIONIC (Cionic, Inc.) is a privately held neurotechnology company headquartered in Scotts Valley, California, that develops the FDA-cleared Neural Sleeve, a wearable bionic garment for individuals with neurological conditions affecting mobility, including multiple sclerosis, stroke, cerebral palsy, spinal cord injury, and traumatic brain injury. The company's core technology, MultiStim, combines functional electrical stimulation with continuous afferent stimulation and proprietary adaptive algorithms driven by on-device IMU kinematics and sEMG sensors; the system can interleave up to 12 independent pulse trains to simultaneously activate weak muscles and relax spastic muscles in real time. CIONIC monetizes through a hardware-plus-recurring-subscription model: a down payment plus monthly installments during Year 1 totaling $3,600 (single leg) or $6,200 (dual leg), transitioning to a $125-$200/month subscription for ongoing Mobility Specialist support, electrodes, and warranty, with a refurbished option at $875 and a side-exchange path for upgrades.

The company operates a multi-channel go-to-market combining direct-to-consumer e-commerce with a 30-second online assessment and virtual onboarding, a prescriber channel of 1,500 physicians and physical therapists nationwide, and a federal channel via its partnership with Lovell Government Services providing veterans access through the VA. CIONIC has raised approximately $35.25 million across five funding rounds through October 2023, with L Catterton (lead, 2023) and BlueRun Ventures (lead, 2022) as flagship investors. It has established clinical and research partnerships with Shirley Ryan AbilityLab, Stanford University, and the National MS Society, and has accumulated 2 million hours of real-world wear time and 500 million stimulated steps across its user base. The Neural Sleeve 2, cleared by the FDA in September 2025, expanded indications to include simultaneous muscle activation and spasm relaxation, and was named a TIME Best Invention of 2025 and Fast Company Most Innovative Company for 2026.

CIONIC firmographics

Firmographics
Name
CIONIC
Legal name
Cionic, Inc.
Website
https://cionic.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
CIONIC builds the FDA-cleared Neural Sleeve, an AI-powered wearable neurotech device using multi-electrode functional electrical stimulation to improve walking for individuals with neurological conditions including MS, stroke, cerebral palsy, and spinal cord injury, sold direct-to-consumer, through 1,500 prescribers, and via the VA channel.
Ownership category
akta.pro rank

CIONIC industry classification

Industry
Product category
Wearable Neurotechnology / Medical Mobility Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHDACAFAL
Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards)
Hardware, Technology & Telecom/Computing Hardware & Peripherals/Input Devices & Accessories (Keyboards, Mice, Controllers)
SECONDARYHDACALAH
Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount)

Keywords

  • Wearable neurotechnology
  • Functional electrical stimulation
  • Mobility assistance devices
  • Neurological rehabilitation tech
  • Bionic clothing

Where CIONIC is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CIONIC business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Neural Sleeve Hardware Sales: Sale of the Neural Sleeve wearable device, which includes the sleeve garment, control unit, and accessories. Customers pay a down payment followed by monthly installments over 12 months, then transition to subscription for ongoing support.
  2. Subscription Services: Ongoing monthly subscription after the first 12 months at $125/month for single leg or $200/month for dual leg. Includes Mobility Specialist support, electrode supply, and extended warranty coverage. Year 1 totals $3,600 (single) or $6,200 (dual).
  3. Refurbished Device Sales: One-time purchase option for prior-generation Neural Sleeves at $875, available through the Certified Refurbished Program. Includes 3 months of service with option to enroll in ongoing subscription.
  4. Professional Services: Mobility Specialist onboarding and follow-up sessions, Fit Confirmation appointments, and a la carte services for customers not on subscription plans.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlySingle Neural Sleeve - Year 1
SubscriptionMonthlyDual Neural Sleeve - Year 1
SubscriptionMonthlySingle Neural Sleeve - Year 2+
SubscriptionMonthlyDual Neural Sleeve - Year 2+
One time/ perpetual licensePay-as-you-goRefurbished Neural Sleeve
Unit PricingPay-as-you-goSide Exchange

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

CIONIC product offering

Product offering

Core offering

CIONIC designs, manufactures, and sells the FDA-cleared Neural Sleeve, a wearable neurotechnology garment that uses AI-powered MultiStim functional electrical stimulation combined with continuous afferent stimulation to improve walking in individuals with neurological conditions such as multiple sclerosis, cerebral palsy, stroke, spinal cord injury, and traumatic brain injury. The system is delivered through an online assessment and prescription workflow, with the Cionic companion app for personalized control and ongoing support from Mobility Specialists, sold via a hardware-plus-subscription model.

Product overview

CIONIC offers a unified bionic mobility system consisting of the Neural Sleeve (a wearable neurotech device combining FDA-cleared Functional Electrical Stimulation with AI-powered real-time gait analysis), the companion Cionic App (for personalized control and progress tracking), and Mobility Specialists (for onboarding and ongoing support). The company also offers a separate Cionic Research Kit for academic and clinical researchers conducting human mobility studies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Neural Sleeve 2 FDA-cleared bionic clothing garment that uses AI-powered MultiStim technology combining functional electrical stimulation and continuous afferent stimulation to improve walking, activate functional muscle movement, and relax muscle spasms for individuals with neurological conditions including MS, cerebral palsy, stroke, and spinal cord injury.
  • Certified Refurbished Neural Sleeve One-time-purchase refurbished Neural Sleeve at $875 that includes the device, 3 months of Mobility Specialist service, electrode supply, and app access, with the option to enroll in the ongoing subscription afterward. Intended for cost-sensitive consumers who want hardware access without committing to the full subscription.
  • Cionic App iOS and Android companion application for Neural Sleeve users that delivers progress measurement, personalized muscle stimulation control, and a growing library of training programs. Sold as part of the Neural Sleeve subscription bundle.
  • Mobility Specialist Support Service Expert-led onboarding, program tailoring, and ongoing support delivered by CIONIC's Mobility Specialists to Neural Sleeve users. Included with active subscriptions and available à la carte for non-subscribers.
  • Cionic Research Kit Standalone research platform for academic and clinical investigators conducting human mobility studies, providing hardware sensors (IMU kinematics up to 400 Hz, sEMG up to 4 kHz), mobile and web applications, a Jupyter analysis environment, HIPAA-compliant infrastructure, and SDKs/REST APIs. Targets research institutions such as Shirley Ryan AbilityLab and Stanford University.

Quantifiable outcome

  • 94% of participants experienced improved gait
  • +7 more outcomes

Companies that use CIONIC

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

CIONIC technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

CIONIC partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Lovell Government ServicescoreChannel Partner/ Reseller/ Distributor · 1 October 2024Partnership with veteran-owned business Lovell Government Services to enhance veterans' access to the Cionic Neural Sleeve through federal healthcare systems. Aims to improve mobility for veterans with neurological conditions including MS.
  • Shirley Ryan AbilityLabcoreStrategic or Co-development PartnerClinical and research partnership with leading rehabilitation research hospital for evidence development and validation.
  • Stanford UniversitycoreStrategic or Co-development PartnerAcademic research partnership for human motion and gait research.
  • National MS SocietycoreStrategic or Co-development PartnerPartnership with leading MS advocacy organization for research and community support.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

CIONIC competitors and assessment

Company assessment

Direct peers

  • Bioness: Bioness is a direct competitor in functional electrical stimulation devices for foot drop and gait rehabilitation, with FDA-cleared L300 Go and H200 products. Both companies target the same neurological mobility patient population with similar FES technology, though CIONIC differentiates with AI-driven adaptive multi-channel stimulation.
  • Saebo: Saebo develops rehabilitation devices for stroke, neurological injury, and mobility impairment, including functional electrical stimulation products and orthoses. Comparable because both companies target the same neurological patient population with clinical evidence-based rehabilitation technology.
  • Compex: Compex (DJO/Enovis) is a leading brand in electrical muscle stimulation devices for rehabilitation, sports performance, and pain management. Comparable because both offer neuromuscular electrical stimulation technology for muscle activation and recovery, though Compex is more consumer/clinical-rehab oriented and CIONIC is more neurological-condition focused.
  • Hasomed: Hasomed develops the RehaMove functional electrical stimulation device for gait rehabilitation and therapy in neurological patients. Comparable as a direct FES competitor in the same patient population, though primarily a clinical/rehab setting device vs. CIONIC's consumer wearable approach.

Broad incumbents

  • Ottobock: Ottobock is a global incumbent in prosthetics, orthotics, and rehabilitation technology with FES products (e.g., L300 Go via acquisition) and broader mobility aids. Comparable because they sell competing FES solutions and complementary mobility devices through established clinical channels and reimbursement networks.
  • Enovis (DJO): Enovis (formerly DJO) is a large medical device company with a broad portfolio in orthopedic, rehabilitation, and pain management products including FES devices. Comparable as a broader incumbent competing in the same FES/rehabilitation space with established payer relationships and clinical sales channels.
  • LivaNova: LivaNova is a global neuromodulation and cardiac surgery company with VNS (vagus nerve stimulation) therapy for epilepsy and depression. Comparable as a broader incumbent in neuromodulation technology applied to neurological conditions, though focused on implantable vagus nerve stimulation rather than wearable FES.

Emerging players

  • Ekso Bionics: Ekso Bionics builds robotic exoskeletons for rehabilitation and mobility assistance in stroke, spinal cord injury, and multiple sclerosis. Comparable because they target the same neurological mobility patient population, though using mechanical exoskeleton technology rather than FES-based wearable stimulation.
  • ReWalk Robotics: ReWalk Robotics develops wearable robotic exoskeletons for individuals with spinal cord injury and other mobility impairments. Comparable in targeting neurological mobility patients with FDA-cleared wearable technology, though using a different modality (powered exoskeleton vs. FES).
  • NeuroPace: NeuroPace develops implantable neurostimulation devices (RNS System) for epilepsy with closed-loop responsive stimulation. Comparable as a neurotechnology company applying AI-driven adaptive stimulation to neurological conditions, though in an implantable form factor for a different indication.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

CIONIC social profiles

Digital presence

CIONIC compliance and trust

Trust signal

Compliance2 records

CIONIC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CIONIC leadership team

Management profile

Number of profiles

Profiles1 record

CIONIC funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CIONIC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CIONIC

What does CIONIC do?

CIONIC designs, manufactures, and sells the FDA-cleared Neural Sleeve, a wearable neurotechnology garment that uses AI-powered MultiStim functional electrical stimulation combined with continuous afferent stimulation to improve walking in individuals with neurological conditions such as multiple sclerosis, cerebral palsy, stroke, spinal cord injury, and traumatic brain injury. The system is delivered through an online assessment and prescription workflow, with the Cionic companion app for personalized control and ongoing support from Mobility Specialists, sold via a hardware-plus-subscription model.

Is CIONIC a public or private company?

CIONIC is a private company. It is classified as venture growth investor backed and is currently operating.

When was CIONIC founded?

CIONIC was founded in 2020. It employs 11 to 50 people.

Where is CIONIC based?

CIONIC is headquartered in San Francisco, United States, in the North America region.

How does CIONIC make money?

Four revenue lines are on record. Neural Sleeve Hardware Sales are the primary driver. The others are subscription Services, refurbished Device Sales and professional Services.

Who are CIONIC's main competitors?

Direct peers on record are Bioness, Saebo, Compex and Hasomed. Broad incumbents are Ottobock, Enovis (DJO) and LivaNova. Emerging players are Ekso Bionics, ReWalk Robotics and NeuroPace.

Does CIONIC have an API?

No public API is recorded for CIONIC.

What industry is CIONIC in?

CIONIC's product category is Wearable Neurotechnology / Medical Mobility Devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HDACAFAL, Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCionic Real-World Evidence Study Examines Quality of Life Across Upper Motor Neuron ConditionsCionic announced its TRANSFORM study, a 12-month real-world quality-of-life study of 1,000 adults with upper motor neuron conditions. Early results from 60 participants show an average EQ-5D improvement of 26% across all five dimensions. The study aims to build a dataset to advance understanding of health-related quality-of-life measures.openPR.comDecentralized Clinical Trials Market Overview, Key Trends, and Major Player AnalysisThe global decentralized clinical trials market is projected to reach $19.55 billion by 2030 with a 17.3% compound annual growth rate, driven by hybrid trial designs, remote monitoring adoption, and AI-driven optimization. Signant Health, a US-based provider specializing in evidence generation for clinical trials, acquired DSG Inc. in July 2023 to strengthen its eClinical offerings by incorporating DSG's unified electronic data capture platform. Additionally, CIONIC introduced enhancements to its FDA-cleared Cionic Neural Sleeve in May 2024, offering new functional exercises and activity tracking for patients with neuromuscular impairments.BitgetCionic's Recognition by Fast Company Ignites Optimistic Search-Based Momentum in NeurotechnologyCionic was recognized by Fast Company as one of the World's Most Innovative Companies in AI and deep technology, representing a third-party validation of the company's bionic apparel technology at a time when it is actively seeking additional capital. The company's flagship Neural Sleeve 2 is an FDA-cleared device that uses AI-powered MultiStim technology to enhance walking and reduce spasms, with clinical data showing 94% of participants experienced improved gait. The article examines whether this recognition will translate into increased search interest and investor attention, while noting the company has raised $35.25 million across five funding rounds, including a $12 million Series A-III in October 2023.PR NewswireCionic Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026Cionic, a San Francisco-based company developing FDA-cleared wearable neurotechnology for mobility, has been named to Fast Company's annual list of the World's Most Innovative Companies for 2026, recognized as a leader in the Medical Device sector. The company released the second generation of its core product, the Neural Sleeve 2, in September 2026, featuring MultiStim technology that choreographs a full gait cycle by combining multiple electrical pulse trains for people with neurological conditions including multiple sclerosis, stroke, and spinal cord injury.BitgetCionic's Recognition by Fast Company Ignites Optimistic Search-Based Momentum in NeurotechnologyCionic has been recognized by Fast Company as one of the world's most innovative companies in artificial intelligence and deep technology, an accolade that provides third-party validation at a time when the company is actively seeking additional capital. The company's flagship Neural Sleeve 2 is the only FDA-cleared system designed to both enhance walking through muscle activation and reduce spasms, backed by clinical evidence showing 94% of participants experienced improved gait. Cionic has raised $35.25 million across five funding rounds, including a $12 million Series A-III in October 2023, with the recognition positioned as a potential catalyst for attracting new investors and scaling manufacturing.EIN PresswireDigital Physiotherapy Wearable Market is Projected to Increase at a CAGR of 16.9% Through 2025-2029The Business Research Company released its 2025 market report projecting the global digital physiotherapy wearable market to grow from $2.03 billion in 2024 to $4.45 billion in 2029, representing a 16.9% CAGR. The report identifies key growth drivers including rising musculoskeletal disorders, increased remote physiotherapy adoption, and enhanced AI and IoT integration in rehabilitation solutions. Cionic, a US biotech firm, received FDA approval in September 2025 for its Neural Sleeve 2 wearable neurotechnology device, marking a significant advancement in AI-powered rehabilitation technology for neurological conditions.ForbesCionic’s Neural Sleeve 2: A Bionic Mobility Aid That Changes EverythingCionic, a Bay Area neurotech startup, received U.S. FDA clearance for its second-generation Neural Sleeve 2, a lower-limb wearable device that uses 24 electrodes with AI-driven functional electrical stimulation to improve gait in patients with neurological conditions such as stroke, spinal cord injury, and multiple sclerosis. The new device introduces a multi-stim approach that simultaneously activates underperforming muscles while relaxing those affected by spasticity, achieving a 30% reduction in spasticity in a trial of 45 users. The company, founded in 2018 by CEO Jeremiah Robison, has partnerships with Shirley Ryan AbilityLab, Stanford University, University of Washington, and multiple sclerosis societies, and is focused on raising clinical awareness while envisioning future bionic clothing as mainstream mobility assistance.TimeCionic Neural Sleeve 2: The Best Inventions of 2025: Special MentionsThe article highlights innovations in wearable and smart technology: Cionic Neural Sleeve 2, an FDA-cleared device aiding muscle movement, and Halter's wireless cattle collars for herd management. Cionic improved its product using data from its earlier device, while Halter expanded its partnership with the U.S. Bureau of Land Management, indicating commercial and strategic development.TracxnTop Companies in Smart Prosthetics (Oct, 2025)The article presents a list of top smart prosthetics startups, highlighting CIONIC, BionicM, REEV, and Össur along with their funding details and product descriptions. It notes that 2025 saw the creation of one new startup in the sector, following an average of six annual launches over the previous decade. The text identifies several universities as common founding backgrounds for these companies.MassDeviceCionic wins FDA nod for next-gen neural sleeve for mobilitySan Francisco-based Cionic announced FDA clearance for its second-generation Neural Sleeve 2, a wearable mobility device that uses AI-driven MultiStim technology to improve walking for people with neurological conditions including multiple sclerosis, cerebral palsy, spinal cord injury, and stroke. The new device expands on the company's first FDA clearance from March 2022 by adding the ability to simultaneously activate muscles and relax muscle spasms. Cionic plans to launch the Neural Sleeve 2 nationwide as it looks to establish what it calls a new benchmark in mobility care.